Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of N-(dibenz(b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) or a pharmaceutically acceptable addition salt thereof for the prophylaxis and/or treatment of muscular dystrophy

Use of N-(dibenz(b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) or a pharmaceutically acceptable addition salt thereof for the prophylaxis and/or treatment of muscular dystrophy

US Patent 7999002 · Granted Aug 16, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biotin-specific monoclonal antibody and use thereof2025
Method for controlling the temperature of a switchgear cabinet for medium-voltag2025
Processes for producing a shaped body using polyamide blends containing a polyar2025
Sinter powder containing a multivalent alcohol for producing moulded bodies2024
Anti-thymidine kinase antibodies2024
Biotin-specific monoclonal antibody and use thereof2024
Sinter powder (SP) comprising a first polyamide component (PA1) and a second pol2024
Electrical circuit for transmitting a useful analogue signal, with a switch and 2024
Sintered powder (SP) containing a partially crystalline terephthalate polyester,2023
Process for producing a polyamide powder by precipitation2023
Sinter powder containing a mineral flame retardant for producing moulded bodies2023
Method for producing a joining connection via welding and joining connection pro2021